Concepedia

Nicholas Rebold

NR

Statistics

Publications

8

Citations

140

H-Index

8

Active since

2021

Affiliations

Wayne State University(Current)

Eugene Applebaum College of Pharmacy and Health Sciences

Detroit Receiving Hospital

Detroit Medical Center

Binghamton University

Nicholas Rebold is an author at Wayne State University specializing in antimicrobial resistance, pharmacotherapy, and antibiotic resistance.

ORCID

Publications per year

2021–2025

8

Publications

8

Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections

Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf et al. · Open Forum Infectious Diseases · 2021 · 32 citations · Full text

, , +17

Risk Factors for Carbapenem-Resistant <i>Enterobacterales</i> Clinical Treatment Failure

Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy et al. · Microbiology Spectrum · 2023 · 24 citations · Full text

, , +17

High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production

Ashlan J. Kunz Coyne, Amer El Ghali, Kristen Lucas et al. · Open Forum Infectious Diseases · 2023 · 21 citations · Full text

, , +17

Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study

Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson et al. · Infectious Diseases and Therapy · 2024 · 15 citations · Full text

, , +17

Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections

Dana Holger, Nicholas Rebold, Sara Alosaimy et al. · Infectious Diseases and Therapy · 2022 · 14 citations · Full text

, , +15

1–5 of 8